Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Myriad Genetics
 More »

  • Gene by Gene Acquires GE-Backed Arpeggi
    Gene to Gene made news June 13, the day the U.S. Supreme Court ruled against Myriad ... States for $995, compared with the $3,340 charged by Myriad for its BRAC Analysis test. ...
    8-7-2013
  • New Gene Patent Suit Sparks Talk of Trolls
    The BRAC Analysis developer is poised to spawn a Myriad of lawsuits. A month after a unanimous U.S. Supreme Court struck down seven Myriad Genetics patents tied to two breast ...
    7-23-2013
  • A Chemist's View of the Supreme Court's Gene Patent Decision
    The case before the Supreme Court is Association for Molecular Pathology et al v Myriad Genetics et al., 569 U.S. ____ (2013). Myriad was granted patents claiming, inter alia, "an ...
    7-18-2013
  • Myriad Sues Ambry, Gene by Gene Amid Confusion Over Supreme Court...
    When the Supreme Court handed down its ruling on contested patents held by Myriad Genetics in June, saying that "a naturally occurring DNA segment is a product of nature and not ...
    7-11-2013
  • Myriad to Perform BRCA Testing in CDx Deal with Tesaro
    Less than two weeks after the Supreme Court struck down its gene patents , Myriad Genetics has moved on, inking an agreement with cancer-focused biopharmaceutical company Tesaro to ...
    6-25-2013
  • A Myriad of Winners
    (AMP) a key victory in overturning Myriad Genetics' seven patents related to its ... And science has come a long way from when Myriad patented the BRCA genes, given the rise ...
    6-17-2013
  • What Did We Learn from Myriad?
    However, the Court ruled that complementary DNA (cDNA) is patent eligible because it is not naturally occurring ( Association for Molecular Pathology et al. v. Myriad Genetics, ...
    6-14-2013
  • Supreme Court Upends Patentability of Genes, but Not cDNA
    At issue is the validity of the seven patents issued to Myriad Genetics for BRCA 1 and 2 by the U.S. Patent and Trademark Office (USPTO). In 2009, 20 medical associations and ...
    6-13-2013
  • Editor's Note: Myriad, the Supreme Court, and Gene Patents
    GEN's John Sterling weighs in. The U.S. Supreme Court's decision on June 13 to invalidate Myriad Genetics' patents on two genes associated with hereditary breast and ovarian cancer ...
    6-13-2013
  • Myriad Genetics Trial: Your Thoughts?
    The U.S. Supreme Court just delivered a mixed decision for companies looking to patent human genes, ruling against Myriad Genetics' patent claims for breast cancer susceptibility ...
    6-13-2013
  • Patent Eligibility of Biological Methods and Compositions
    We also comment on the recent oral argument held on April 15, 2013, in Association for Molecular Pathology et al. v. Myriad Genetics, Inc., et al. before the US Supreme Court. ...
    6-3-2013
  • Monsanto Seed Wars Sprout Controversy
    ... Over the next several days, the Supreme Court will deliver another blockbuster decision in another closely watched patentability case. Myriad Genetics is trying to protect its ...
    5-29-2013
  • Companion Diagnostics: 52 Pick-Up
    ... Financial terms not disclosed. Myriad Genetics and Teva Pharmaceutical (Cephalon) Agreement announced March 28, 2012 Collaboration to test for BRCA1 and BRCA2 mutation via Myriad's ...
    5-9-2013
  • Biomarkers Take Center Stage
    ... Developing New Assays for Cancer Biomarkers Researchers at Myriad RBM and the Cancer ... Nothing-from lifestyle choices to birth order to ancestral genetics and epigenetics-is off ...
    5-1-2013
  • $20M in Financing Helps RainDance Summon ThunderStorms for Myriad
    In addition to making some money, RainDance Technologies has made a new friend: RainDance is closing a $20 million Series E financing round, and Myriad Genetics is now a new ...
    4-29-2013

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll